GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 10246810155

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10246810155 and manufactured by LABORLAB PRODUTOS PARA LABORATÓRIOS LTDA EPP. The registration is held by LABORLAB PRODUTOS PARA LABORATÓRIOS LTDA EPP with validity until currently active (VIGENTE).

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10246810155
2 Related Devices
Registration Details
ANVISA Registration Number: 10246810155
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

HbA1c enzymatic Control
Risk Class II

Registration Details

10246810155

25351420247201455

72807043000194

Company Information

Brazil
PT: BRASIL

Dates and Status

Nov 03, 2014

VIGENTE

09/18/2025 19:00:01

HbA1c enzymatic Control
Risk Class II

Registration Details

10246810155

25351420247201455

72807043000194

Company Information

Argentina
PT: ARGENTINA

Dates and Status

Nov 03, 2014

VIGENTE

09/18/2025 19:00:01